Encompass Health Corp Stock Price, News & Analysis

Encompass Health (EHC) and Piedmont have announced the opening of the Rehabilitation Hospital of Athens in Georgia, a 40-bed inpatient facility located at 1083 Parkway Blvd. This joint venture represents EHC's 167th rehabilitation hospital nationwide and 8th location in Georgia.

The facility offers specialized care for patients recovering from strokes, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions. Patients receive minimum three hours of intensive therapy five days weekly, frequent physician visits, and 24-hour nursing care.

The hospital features private patient rooms, advanced rehabilitation technologies, an activities suite, in-house dialysis suite, therapy courtyard, dining room, pharmacy, and dayroom areas. This marks the seventh operational joint venture between Encompass Health and Piedmont, with plans announced for an additional facility in Loganville, Georgia.

Encompass Health (NYSE: EHC) has announced its participation in the upcoming Barclays Global Healthcare Conference, scheduled for March 11-13, 2025. The company's presentation will feature President and CEO Mark Tarr alongside Executive VP and CFO Doug Coltharp.

The presentation is set for Tuesday, March 11, 2025, from 8:30 to 8:55 AM ET. Investors and interested parties can access the live webcast through the company's investor relations website at http://investor.encompasshealth.com.

Encompass Health (NYSE: EHC) has announced a quarterly cash dividend declaration by its board of directors. Shareholders will receive $0.17 per share as a cash dividend. The dividend will be paid on April 15, 2025, to stockholders who are registered as holders of record on April 1, 2025.

Encompass Health (NYSE: EHC) reported strong Q4 2024 results with significant growth across key metrics. Net operating revenue increased 12.7% to $1,405.0 million, driven by a 7.8% growth in discharges and 4.2% increase in net patient revenue per discharge. Same-store discharge growth was 5.8%.

The company's income from continuing operations per diluted share rose 25.5% to $1.18, while adjusted earnings per share increased 23.2% to $1.17. Cash flows from operating activities grew 38.7% to $278.8 million, and adjusted EBITDA improved 13.6% to $289.6 million.

For 2025, EHC provided guidance projecting net operating revenue between $5,800 to $5,900 million, adjusted EBITDA of $1,160 to $1,200 million, and adjusted earnings per share from continuing operations of $4.67 to $4.96.

Encompass Health (NYSE: EHC) has been named to Fortune's World's Most Admired Companies list for 2025, marking its fifth consecutive year receiving this recognition. As the nation's largest owner and operator of inpatient rehabilitation hospitals, this achievement highlights the company's commitment to exceptional patient care and stakeholder trust.

The selection process, conducted in collaboration with Korn Ferry, evaluated companies from an initial pool of the 1,000 largest U.S. companies by revenue and non-U.S. Global 500 companies with revenues exceeding $10 billion. The final list was narrowed to 650 companies across 30 countries. Companies were rated on nine criteria, including investment value, management quality, product quality, social responsibility, and talent attraction. Those scoring in the top half of their respective industries earned a place on the prestigious list.

Encompass Health (NYSE: EHC) has announced its schedule for reporting Q4 2024 financial results. The company will release its fourth quarter results, ending December 31, 2024, after market close on Thursday, February 6, 2025.

The company will hold an investor conference call the following day, Friday, February 7, 2025, at 10 a.m. ET. Investors can join via phone by dialing 800-579-2543 (US) or 785-424-1789 (International) using conference ID EHCQ424. A live webcast and replay will be available on the company's investor website.

Encompass Health (NYSE: EHC) has achieved recognition on Forbes' inaugural list of the Most Trusted Companies in America. The company, which stands as the nation's largest owner and operator of inpatient rehabilitation hospitals, secured the fourth position among companies in the Health Care Equipment and Services category.

The evaluation process, conducted in partnership with HundredX, Signal AI, and Glassdoor, examined over 2,000 large U.S.-based public companies. The assessment focused on four key areas: customer trust, employee trust, investor trust, and media sentiment, analyzing hundreds of millions of data points. Only 300 companies made the final list.

Mark Tarr, president and CEO, emphasized the company's dedication to being the trusted choice in inpatient rehabilitation and highlighted their commitment to providing compassionate, high-quality, individualized care to achieve optimal patient outcomes. The company aims to continue expanding its presence nationwide to meet service demands.

Encompass Health (NYSE: EHC) has announced preliminary plans to construct a 50-bed inpatient rehabilitation hospital in Bangor, Maine, at 1017 Union Street. The facility, set to open in 2027, will be the company's second hospital in Maine and will provide specialized care for patients recovering from various conditions including strokes, neurological disorders, brain injuries, spinal cord injuries, amputations, and complex orthopedic conditions.

The new hospital will feature private rooms, advanced rehabilitation technologies, an activities suite, in-house dialysis, pharmacy, and therapy courtyard. It will offer 24-hour nursing care along with physical, occupational, and speech therapies, delivered by specialized healthcare professionals.

Encompass Health and Enhabit have won a significant lawsuit in the Delaware Court of Chancery against former senior officers April Anthony, Luke James, and Chris Walker for breaches of fiduciary duty. The Court also ruled against private equity firms Vistria Group and Nautic Partners for aiding these breaches.

The Court found that the defendants misappropriated acquisition opportunities, used confidential information, and recruited key employees while still employed at Encompass Health. As compensation, the Court awarded 43% of VitalCaring Group's profits to Encompass Health and Enhabit, plus $1.62 million in mitigation damages and attorneys' fees.

The defendants were found to have deliberately concealed their actions through falsifying records, deleting evidence, and manipulating communications. The Court's decision sends a clear message about the consequences of breaching fiduciary duties and self-dealing by corporate officers.